Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

140 PROCARE – phase 2 KCE reports 81RATE OF ACUTE GRADE 4 CHEMOTHERAPY-RELATEDCOMPLICATIONSMeasurement in prospective PROCARE database (Figure 50)Patients with (y)p Stage 0-III are selected through variable ‘PT_V151’. The subgrouptreated with surgery is selected using variable ‘AD_V111’. Within this selection, patientsreceiving adjuvant chemo(radio)therapy are selected with variable ‘CH_V104’.Chemo(radio)therapy-related complications are registered through variables ‘CH_V136’– ‘CH_V144’, the grade is registered with variable ‘CH_V146’.Measurement in coupled administrative databaseNo specific administrative codes are available for chemotherapy-related complications.In the ICD-9-CM coding system some aspecific codes are available (e.g. 963.1 poisoningby primarily systemic agents: antineoplastic and immunosuppressive drugs), but there isno mentioning of grade. Therefore, these codes cannot be used. The QI is notmeasurable.Figure 50. Algorithm for QI 1245 (prospective database).All patientsN=1071Adjuvant chemo(radio)therapyN=68N=0Grade 40%pyp-Stage 0-I-II-IIIGrade 3Stage?N=841N=5SurgeryN=841Gradeadverseevent?NO adverse eventoradverse event=MISSINGN=42Surgery?Grade : MISSINGNo surgeryN=0Adjuvantchemo(radio)therapy?Adjuvant radiotherapy onlyN=0N=9No chemo-questionnairefilled outN=12pyp-Stage IVN=49No adjuvant treatmentN=347N=724pyp-Stage unknownN=181Adjuvant treatmentchemotherapy=MISSINGN=426
KCE Reports 81 PROCARE – phase 2 141RATE OF CSTAGE IV PATIENTS RECEIVING CHEMOTHERAPYMeasurement in prospective PROCARE database (Figure 51)Patients with cStage IV RC are selected through variable ‘PT_V151’. Those patientsreceiving chemotherapy are selected with variables ‘AD_V114’, ‘AD_V118’ and‘AD_V122’.Measurement in coupled administrative database (Figure 52)Patients with cStage IV are selected using the BCR database. Data on chemotherapy areavailable in the HIC database (Table 72), which are used to select those cStage IVpatients receiving chemotherapy.Figure 51. Algorithm for QI 1251 (prospective database).All patientsN=1071c-Stage IVN=111N=68ChemotherapyN=61,26%Stage?Chemotherapy?C-Stage 0-I-II-IIIN=625No chemotherapyN=43c-Stage UnknownN=335
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100: KCE Reports 81 PROCARE - phase 2 89
Page 149: KCE Reports 81 PROCARE - phase 2 13
Page 169: KCE Reports 81 PROCARE - phase 2 15
Page 172 and 173: Dépôt légal : D/2008/10.273/39
Page 174 and 175: 35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

Create successful ePaper yourself

Delete template?

Save as template?